External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home Oncology WCLC 2025
Roche and Genentech at

WCLC 2025

September 06 - September 09
Barcelona, Spain / Virtual (Hybrid)
wclc.iaslc.org
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon
10:02 AM
Duration 10mins Room 06
SKYSCRAPER-05: Phase II Study of Neoadjuvant Tiragolumab + Atezolizumab Chemotherapy in Locally Advanced Resectable NSCLC
Pass H, Felip E, Shu C, Frueh M, Hong MH, Marti AM, Meng R, Troutman S, Parsons C, Tran C, Hsu J, Gitlitz B, Kim A, Ferris A
Oncology | Lung Cancer

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
10:07 AM
Duration 5mins Room 01
Nautika1: Clinical Outcomes and Pathologic Regression With Neoadjuvant Alectinib in Resectable Stage IB-IIIB ALK + NSCLC
Lee J. M., Negrao M. V., Cummings A., Shum E., Patil T., Lin J., Shu C. A., Saltos A., Florez N., Blakely C.M., Sholl L., Saqi A., Ding B., Zhu Q., Schulze K., Grindheim J., Bara I., Ngiam C., Chaft J.
Oncology | Lung Cancer

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
11:20 AM
Duration 5mins Room 01
Safety of Lurbinectedin + Atezolizumab as 1L Maintenance Treatment in ES-SCLC: Results From the Phase 3 IMforte Study
Reck M., Borghaei H., Liu S. V., Peters S., Herbst R. S., Szczesna A., Cubukcu E., Kiliçkap S., Wei Y-F., Rittmeyer A., Fountzilas E., Kaul M. Lin Y-C., Mohan S., Bhatt K., Daniels M., Wang X., Paz-Ares L.
Oncology | Lung Cancer

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
11:35 AM
Duration 5mins Room 06
IMscin002 final analysis: patient preference and safety of atezolizumab by subcutaneous and intravenous administration
Cappuzzo F, Zvirbule Z, Korbenfeld E, Kolb-Sielecki J, Isla D, Castro-Sanchez AY, Bustillos A, Herraez-Baranda L, Barata T, Young F, Majem M
Oncology | Lung Cancer

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
01:00 PM
Duration 5mins Barcelona, Spain
Liquid Biopsy Shortens Time to Diagnosis and Treatment Selection: Primary Results from the International L1st Study
Fabrice Barlesi, Vivek Muthu, Luisa Sánchez Lorenzo, Anne-Marie Baird, Solange Peters, Fethi Touri, Mehlika Hazar Rethinam, Nasséra Chalabi, C. Benedikt Westphalen, Fortunato Ciardiello
Oncology | Lung Cancer

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.